Article
Tom Caravela
LinkedIn: Why you need it. How to use it!
Summary
In this episode, Jill Vanak joins the discussion to explore the transformative role of LinkedIn in career development. Jill shares her journey into career coaching and emphasizes the importance of optimizing LinkedIn profiles to align with resumes. The conversation delves into effective networking and engagement strategies, offering insights on leveraging LinkedIn for niche career paths and enhancing visibility through active participation. Jill distinguishes between endorsements and recommendations, addresses challenges in content creation, and provides tips on personalizing LinkedIn features. The episode wraps up with final advice for advancing careers through LinkedIn, followed by closing remarks and expressions of gratitude.
My guest today is Jill Vanak, Clinical Research Practitioner at Janssen Oncology, Early Development. We talk about LinkedIn, why it is important, why you need it, and how to use it.
In this episode we discuss:
- Who is Jill and what she does
- LinkedIn - where do people start?
- Tips and tricks to know as it relates to the profile
- Mistakes or missing pieces she typically sees with LinkedIn profiles
- Ways people should be engaging on LinkedIn
- Developing content for LinkedIn - does everyone need to be posting articles, images, quotes, etc?
- How much time should people be spending on LinkedIn in Jill’s opinion
- Her advice as it relates to engagement, job search, and career development
LinkedIn optimization, career development, networking strategies, content creation tips, LinkedIn engagement
Related Topics
You May Also Like
Tom Caravela
Podcast
MSL Talk: Tom Caravela, Ike Ogbaa
How to Build Scientific Credibility for Continuous Career Development
Podcast
MSL Talk: Tom Caravela, Archie Stone
Why Chasing Titles is Fools Gold
Article
Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
Article
Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
Article
Vanessa Arciero, BS, Seanthel Delos Santos, Liza Koshy